# K2 Therapeutics

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/k2-therapeutics

- Industry: Biotechnology
- Headquarters: Singapore, Singapore
- Website: www.k2tx.com
- Total disclosed funding: $50M
- Latest round: Seed (Aug 11, 2026)
- Investors on record: 1

## About

Founded in 2024 and based in Singapore, K2 Therapeutics, Inc. operates as a biotechnology company that develops drug candidates and cell therapies for cancer and other diseases through global drug development programs.

## Funding rounds

- Seed, Aug 11, 2026, $50M — MPM BioImpact

## Investors

- MPM BioImpact (https://capitalatlas.ai/funds/mpm-bioimpact) — Seed